APA (7th ed.) Citation

Cabrera-Rode, E., Perich, P., Diaz-Horta, O., Tiberti, C., Molina, G., Arranz, C., . . . Dimario, U. (2002). Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies is Related to Glibenclamide Treatment. Autoimmunity, 35(7), 469. https://doi.org/10.1080/0891693021000050574

Chicago Style (17th ed.) Citation

Cabrera-Rode, Eduardo, et al. "Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies Is Related to Glibenclamide Treatment." Autoimmunity 35, no. 7 (2002): 469. https://doi.org/10.1080/0891693021000050574.

MLA (9th ed.) Citation

Cabrera-Rode, Eduardo, et al. "Slowly Progressing Type 1 Diabetes: Persistence of Islet Cell Autoantibodies Is Related to Glibenclamide Treatment." Autoimmunity, vol. 35, no. 7, 2002, p. 469, https://doi.org/10.1080/0891693021000050574.